Signal from the log
Microinstruments
125 M$ · Series D and later · Italy · Medtech
MMI fabrique Symani, un robot de microchirurgie ouverte qui filtre le tremblement et réduit les gestes du chirurgien sur des instruments miniatures, pour réparer vaisseaux lymphatiques et nerfs. Une cinquantaine de systèmes sont installés selon la société. Série D menée par BioStar Capital, déjà au capital.
Verified
Announced on , logged by the watch of 8 October 2026.
- Operation
- Funding round
- Announced amount
- 125 M$
- Stage
- Series D and later
- Country
- Italy
- Sector
- Medtech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by BioStar Capital , with S3 Ventures , Angelini Ventures , Investisseur stratégique non divulgué
Provenance
Source divenewsletter,sifted
Logged on 8 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.